PMV Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMVP and other ETFs, options, and stocks.About PMVP
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J.
CEODavid H. Mack
CEODavid H. Mack
Employees47
Employees47
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2013
Founded2013
Employees47
Employees47
PMVP Key Statistics
Market cap69.15M
Market cap69.15M
Price-Earnings ratio-0.84
Price-Earnings ratio-0.84
Dividend yield—
Dividend yield—
Average volume711.07K
Average volume711.07K
High today$1.36
High today$1.36
Low today$1.29
Low today$1.29
Open price$1.30
Open price$1.30
Volume180.65K
Volume180.65K
52 Week high$1.84
52 Week high$1.84
52 Week low$0.81
52 Week low$0.81
Stock Snapshot
PMV Pharmaceuticals(PMVP) stock is priced at $1.31, giving the company a market capitalization of 69.15M. It carries a P/E multiple of -0.84.
On 2025-11-06, PMV Pharmaceuticals(PMVP) stock traded between a low of $1.29 and a high of $1.36. Shares are currently priced at $1.31, which is +1.2% above the low and -4.0% below the high.
PMV Pharmaceuticals(PMVP) shares are trading with a volume of 180.65K, against a daily average of 711.07K.
In the last year, PMV Pharmaceuticals(PMVP) shares hit a 52-week high of $1.84 and a 52-week low of $0.81.
In the last year, PMV Pharmaceuticals(PMVP) shares hit a 52-week high of $1.84 and a 52-week low of $0.81.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own PMVP. This list is generated using Robinhood data, and it’s not a recommendation.